Kumar, N., Kumar, S., Shukla, A., Kumar, S., Singh, R. K., Ulasov, I., . . . Acharya, A. (2026). Correction: Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced inhibition of Dalton's lymphoma growth and proliferation. Discover Oncology, 17(1), 1. https://doi.org/10.1007/s12672-026-05021-0
Παραπομπή σε μορφή Chicago (17η εκδ.)Kumar, Naveen, et al. "Correction: Mitochondrial-mediated Apoptosis as a Therapeutic Target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced Inhibition of Dalton's Lymphoma Growth and Proliferation." Discover Oncology 17, no. 1 (2026): 1. https://doi.org/10.1007/s12672-026-05021-0.
Παραπομπή σε μορφή MLA (9th εκδ.)Kumar, Naveen, et al. "Correction: Mitochondrial-mediated Apoptosis as a Therapeutic Target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced Inhibition of Dalton's Lymphoma Growth and Proliferation." Discover Oncology, vol. 17, no. 1, 2026, p. 1, https://doi.org/10.1007/s12672-026-05021-0.